4.6 Review

New Trends of Deep Learning in Clinical Cardiology

期刊

CURRENT BIOINFORMATICS
卷 16, 期 7, 页码 954-962

出版社

BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/1574893615999200719234517

关键词

Clinical; cardiology; artificial intelligent; machine learning; deep learning; neural networks

资金

  1. National Natural Science Foundation of China [21402032, 21262005, 21775061]
  2. Foundation of Guangxi Key Laboratory of Functional Phytochemicals Research and Utilization Guangxi [FPRU2016-4]
  3. Natural Science Foundation of Shandong Province [ZR2018JL012]
  4. Foundation of Key Laboratory of Trusted Software [kx201703]
  5. Guangxi Innovation-Driven Development Project [GuiKeAA18242040]
  6. Guangxi Key Laboratory of Traditional Chinese Medicine Quality Standards (Guangxi Institute of Traditional Medical and Pharmaceutical Sciences) [guizhongzhongkai201703]

向作者/读者索取更多资源

Deep Learning (DL) is a novel type of Machine Learning (ML) model that shows promise in clinical cardiology and medicine in general. Various DL models have been applied in analyzing arrhythmias, electrocardiograms, ultrasonic data, genomes, and biopsies, demonstrating the power of deep learning algorithms in clinical predictive modeling. Future advancements in deep learning are expected to further impact the field of clinical medicine.
Deep Learning (DL) is a novel type of Machine Learning (ML) model. It is showing an increasing promise in medicine, study and treatment of diseases and injuries, to assist in data classification, novel disease symptoms and complicated decision making. Deep learning is one of form of machine learning typically implemented via multi-level neural networks. This work discusses the pros and cons of using DL in clinical cardiology that is also applied in medicine in general while proposing certain directions as more viable for clinical use. DL models called deep neural networks (DNNs), recurrent neural networks (RNNs) and convolutional neural networks (CNNs) have been applied to arrhythmias, electrocardiogram, ultrasonic analysis, genomes and endomyocardial biopsy. Convincingly, the results of the trained model are satisfactory, demonstrating the power of more expressive deep learning algorithms for clinical predictive modeling. In the future, more novel deep learning methods are expected to make a difference in the field of clinical medicines.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据